ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,349,000 | -18.5% | 950,129 | +0.5% | 0.00% | 0.0% |
| Q3 2016 | $1,655,000 | +2.2% | 945,725 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $1,620,000 | -1.7% | 947,551 | +13.3% | 0.00% | 0.0% |
| Q1 2016 | $1,648,000 | +6.6% | 836,603 | +2.8% | 0.00% | 0.0% |
| Q4 2015 | $1,546,000 | -0.8% | 813,789 | -0.3% | 0.00% | 0.0% |
| Q3 2015 | $1,558,000 | -59.1% | 815,877 | -0.6% | 0.00% | -60.0% |
| Q2 2015 | $3,807,000 | +30.4% | 820,461 | +22.8% | 0.01% | +25.0% |
| Q1 2015 | $2,920,000 | +40.2% | 668,239 | +11.4% | 0.00% | +33.3% |
| Q4 2014 | $2,082,000 | -17.8% | 599,904 | -0.8% | 0.00% | -25.0% |
| Q3 2014 | $2,533,000 | -28.1% | 604,639 | +0.6% | 0.00% | -20.0% |
| Q2 2014 | $3,523,000 | -9.6% | 601,165 | -2.9% | 0.01% | -16.7% |
| Q1 2014 | $3,899,000 | +8.3% | 618,938 | +0.5% | 0.01% | +20.0% |
| Q4 2013 | $3,601,000 | +8.3% | 615,624 | -2.5% | 0.01% | 0.0% |
| Q3 2013 | $3,326,000 | -27.8% | 631,159 | +5.5% | 0.01% | -37.5% |
| Q2 2013 | $4,608,000 | – | 598,385 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |